ArticleBMJ open2026
Multidimensional correlates of adherence to cardiovascular treatment among patients with multimorbidity from tribal communities in South India: an exploratory cross-sectional study.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTribal people in India face a growing risk of multimorbidity, primarily from cardiovascular diseases (CVD) due to changing lifestyles and unique socio-cultural and political factors. We aimed to identify treatment patterns and barriers to medication adherence for CVD. This will inform culturally sensitive implementation strategies that may improve outcomes among tribal communities.
methodsWe conducted an exploratory cross-sectional study among participants with multimorbidity in a South-Indian tribal setting. We used a structured questionnaire, guided by the Consolidated Framework for Implementation Research(CFIR), to assess comorbidities, treatment patterns, adherence and potential factors influencing adherence. Descriptive statistics and multivariable logistic regression identified correlates for medication non-adherence.
resultsWe recruited 200 participants with a mean age of 64.6±9.71 years. The majority were female (115, 57.5%), of tribal origin (160, 80%) and had no formal education (169, 84.5%). The commonly reported comorbidities included hypertension (168, 84%) and diabetes (113, 56.5%) followed by chronic kidney disease (CKD) (47, 24%). Self-reported non-adherence to medications (missing at least one CVD pill in the past week) was reported by 120 (60%) participants. Key correlates of non-adherence identified were lower levels of education (OR 8.27, 95% CI 1.96 to 35.01, p=0.004), diabetes (2.94, 95% CI 1.04 to 8.33, p=0.04) and high pill burden (5.04, 95% CI 1.88 to 28.84, p=0.03), while social support (0.85, 95% CI 0.7 to 0.97, p=0.013) and positive illness perception (0.95, 95% CI 0.91 to 0.99, p=0.05) were positively associated with good adherence.
conclusionThese tribal communities face complex challenges in managing CVD and multimorbidity. Improving adherence will require developing simple, patient-centred and culturally appropriate strategies through community engagement. Simplified medication regimens, including rational fixed dose combination pills may improve adherence. Additionally, the high prevalence of CKD observed underscores the need for investigation and integration of regular CKD screening in the health system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.